KLOW Blend
KLOW Blend is an advanced 80mg four-peptide complex combining BPC-157, GHK-Cu, TB-500, and KPV for comprehensive tissue repair with integrated inflammatory control. Building on the GLOW foundation, KPV adds direct NF-κB inhibition and cytokine suppression to the vascular priming, matrix synthesis, and cellular migration mechanisms. This complete formulation addresses both regenerative processes and inflammatory modulation simultaneously, making it ideal for research protocols requiring simultaneous tissue repair and inflammation control.
CJC-1295 (No DAC) is a modified GRF(1-29), a 29-amino acid GHRH analog with four amino acid substitutions that enhance alpha-helical structure and confer 49x greater receptor potency versus native GHRH. The No DAC version features a shorter in vivo half-life (~30 minutes) designed for discrete pulsatile GH signal research, allowing researchers to study physiological growth hormone release patterns without the extended release profile of the DAC-modified version.
CJC-1295 functions as a potent GHRH receptor agonist, binding to and activating growth hormone-releasing hormone receptors on pituitary somatotroph cells. The four amino acid substitutions (Aib, Gln, Ala, and Leu at positions 2, 8, 15, and 27) protect against enzymatic degradation while maintaining receptor binding affinity. This structural modification results in significantly enhanced stability and bioavailability compared to unmodified GRF(1-29).
In research applications, CJC-1295 (No DAC) stimulates pulsatile growth hormone release, leading to increased IGF-1 production in hepatic and peripheral tissues. The absence of the Drug Affinity Complex (DAC) means the peptide does not bind to albumin for extended circulation, resulting in a more physiological release pattern that mimics natural GH pulsatility. This makes it particularly valuable for research protocols requiring precise temporal control over GH signaling.
The peptide demonstrates remarkable efficacy in stimulating GH release without significantly affecting cortisol, prolactin, or other stress hormone levels when used appropriately. This selectivity makes it a preferred research tool for studying GH axis function, anabolic processes, metabolic regulation, and age-related endocrine changes without confounding effects from other hormonal systems.
| Compound | MW / Formula | CAS No. | Sequence / Structure | Receptor / Target |
|---|---|---|---|---|
| CJC-1295 (No DAC) | ~3367 g/mol | 863288-34-0 | 29-AA GHRH fragment; 4× substitutions; 49× native GHRH potency | Modified GRF(1-29); GHRH receptor agonist |
The following compounds operate through distinct, non-overlapping mechanisms that complement this product's research pathways. Each is independently available from the General Peptide catalog.
GLOW Blend is a precision-formulated 70mg triple-peptide complex combining BPC-157, GHK-Cu, and TB-500 for comprehensive tissue repair research. By uniting three distinct mechanisms, it addresses sequential regenerative phases. BPC-157 primes t...
NAD+ is a vital dinucleotide coenzyme present in all living cells, central to cellular energy, DNA repair, and signaling. It fuels ATP production and acts as the rate-limiting substrate for Sirtuins, PARPs, and CD38 enzymes. Because NAD+ levels...
Thymalin (Thymulin; CAS 66017-93-4; MW 857.9 g/mol) is a 9-amino acid zinc-dependent polypeptide bioregulator produced by the thymus gland that restores thymic microenvironment function and normalizes T-lymphocyte and B-lymphocyte counts. Disti...
Epithalon is a highly stable synthetic tetrapeptide modeled after a natural pineal gland polypeptide. It functions as a potent telomerase activator and bioregulator, working to elongate telomeres, extend cellular replicative lifespan, and norma...
SS-31 (Elamipretide; D-Arg-Dmt-Lys-Phe-NH2; CAS 736992-21-5; MW 639.8 g/mol) is a D-amino acid tetrapeptide that selectively targets the inner mitochondrial membrane through electrostatic interaction with cardiolipin. Accumulating at ~10,000x g...